UH Cancer Center, Queen’s Health partner on Hawai‘i’s first on-campus cancer clinical center

Efti + radiotherapy + Keytruda regimen meets primary endpoint in phase II study in soft tissue sarcoma

Investigator-initiated EFTISARC-NEO phase II trial evaluating eftilagimod alfa (efti) with radiotherapy plus Keytruda (pembrolizumab) in the neoadjuvant setting for resectable soft tissue sarcoma has met its primary endpoint.

May 30, 2025

Vol.51 No.21

Regulatory News

ODAC marathon: Committee charges through a pileup of clinical questions in a two-day, four-application session

In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.

FDA grants accelerated approval to avutometinib + defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer

FDA has approved Avmapki Fakzynja Co-Pack (avutometinib capsules; defactinib tablets) for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer who received prior systemic therapy. Avmapki Fakzynja Co-Pack is the first and only FDA-approved medicine for this disease.

May 23, 2025

Vol.51 No.20

In Brief

UT Southwestern breaks ground on $177M radiation oncology campus in Fort Worth

UT Southwestern Medical Center broke ground May 12 on a $177 million radiation oncology campus that will provide advanced therapies for patients of Fort Worth, TX, the nation’s 12th-largest city.

May 16, 2025

Vol.51 No.19

In Brief

City of Hope opens largest outpatient cancer center in its national system

City of Hope opened its largest outpatient facility among its network of 38 U.S. locations—Hope Plaza.

May 16, 2025

Vol.51 No.19

In Brief

RWJBarnabas Health, Rutgers open NJ’s first and only freestanding cancer hospital

RWJBarnabas Health and Rutgers Cancer Institute, the state’s only NCI-designated Comprehensive Cancer Center, have opened New Jersey’s first and only freestanding, fully comprehensive cancer hospital (The Cancer Letter, April 25, 2025).

May 16, 2025

Vol.51 No.19

UH Cancer Center, Queen’s Health partner on Hawai‘i’s first on-campus cancer clinical center

YOU MAY BE INTERESTED IN

Efti + radiotherapy + Keytruda regimen meets primary endpoint in phase II study in soft tissue sarcoma

ODAC marathon: Committee charges through a pileup of clinical questions in a two-day, four-application session

FDA grants accelerated approval to avutometinib + defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer

UT Southwestern breaks ground on $177M radiation oncology campus in Fort Worth

City of Hope opens largest outpatient cancer center in its national system

RWJBarnabas Health, Rutgers open NJ’s first and only freestanding cancer hospital

Renew today!

Subscriber content

Never miss an issue!

Login